James Shimota

Practices

Education and Clerkships

J.D., University of Michigan Law School, 1999, magna cum laude

B.S.E., Chemical Engineering, University of Michigan, 1996, magna cum laude

  • Law Clerk to the Honorable James L. Ryan, U.S. Court of Appeals for the Sixth Circuit

Admissions

Illinois, 1999

Court Admissions

U.S. Court of Appeals for the Federal Circuit

U.S. Court of Appeals for the Sixth Circuit

U.S. District Court for the Northern District of Illinois

Profile

James Shimota concentrates his practice on all aspects of post-issuance patent practice. He has extensive experience before judges and juries in federal courts across the country as well as the United States International Trade Commission and arbitration panels. Representative technologies with which Jim has worked include financial services products, multiple aspects of cellular and smartphone technology, semiconductor manufacturing, fiber optic amplifiers, DNA arrays, HIV drugs, alkaline batteries, wireless networking products, power supplies, cleaning systems for portable shavers, memory image sensors, portable music players, and automated tissue staining instruments.

Jim also counsels clients on building patent portfolios inorganically through strategic acquisitions. Jim provides advice to technology companies in industries such as consumer electronics, electronic commerce and pharmaceutical regarding what patent assets do and don’t complement existing organic patent assets and how much those assets are worth. For example, Jim assisted an international client in completing a multi-billion dollar patent portfolio acquisition involving thousands of patents.

Jim further focuses on advising venture capitalists and startups on patent strategy.

Jim was selected for inclusion in Illinois Super Lawyers − Rising Stars Edition, Thomson Reuters, 2013-2014 and recognized in the Intellectual Property Litigation category of Illinois Super Lawyers, Thomson Reuters in 2018-2019.

Honors

Super Lawyers

Jim Shimota Named Illinois Super Lawyer in 2019

Haynes and Boone Partner Jim Shimota has been recognized in the Intellectual Property Litigation category of the Illinois 2019 Super Lawyers (Thomson Reuters) annual award listing.

Selected Client Representations

  • Voxiva, Inc. v. MyHealth, Inc. (D. Del)
  • FarmedHere, LLC et al v. Just Greens, LLC d/b/a AeroFarm Systems, LLC (Arbitration)
  • Velocity Patent LLC v. Chrysler, BMW, Mercedes, Jaguar Land Rover and Audi (N.D. Ill.)
  • UMF Corp. v. Tadgreen, Inc. (N.D. Ill.)
  • General Components, Inc. v. Mott Corp. et al. (E.D. Va.)
  • General Components, Inc. v. Fujikin, Inc. (International Arbitration)
  • Intel Corp. v. Wi-LAN Inc. (N.D. Cal.)
  • Eastman Chemical Co. v. AlphaPet Inc. (D. Del.)
  • Masonite Corporation v. CraftMaster, Inc. (N.D. Ill.)
  • Every Penny Counts, Inc. v. Bank of America (M.D. Fla.)
  • Mosaid Technologies, Inc. v. Micron Technology, Inc. (E.D. Tex.)
  • Litton Systems, Inc. v. Lucent Technologies Inc. (C.D. Cal.)
  • CytoLogix Corp. v. Ventana Medical Systems, Inc. (D. Mass.)
  • Braun v. Spectrum Brands, Inc. (D. Mass.)
  • Mosaid v. Infineon (E.D. Tex.)
  • Illinois Tool Works Inc. v. Thermal Dynamics (E.D. Wis.)
  • Agere Systems, Inc. v. Broadcom (E.D. Pa.)
  • Medline Indus., Inc. v. Maersk Med. Ltd., Giltech Ltd., and Tyco HealthcareGroup LP (N.D. Ill.)
  • Eveready Battery Company v. Rayovac Corporation (N.D. Ohio)

Intellectual Property

IP Beacon Year in Review 2018

The Intellectual Property Law 2018 Year In Review

We are pleased to highlight some of our representative intellectual property-related client successes and publications over the past year that might be relevant to your business success in the coming year. We represented clients in 74 inter partes review/PTAB proceedings that were filed in 2018, and our patent prosecution team filed over 2,300 U.S. patent applications and helped issue more than 1,650 U.S. patents just in 2018. We also helped close the IP issues in dozens of financings, M&A transactions, and joint venture/licensing arrangements.

Email Disclaimer